Cargando…
Progressive supranuclear palsy’s economical burden: the use and costs of healthcare resources in a large health provider in Israel
BACKGROUND: Progressive supranuclear palsy (PSP) is a rare and fatal neurodegenerative movement disorder with no disease modifying therapy currently available. Data on the costs associated with PSP are scarce. This study aims to assess the direct medical expenditure of patients with PSP (PwPSP) thro...
Autores principales: | Barer, Yael, Cohen, Raanan, Grabarnik-John, Meital, Ye, Xiaolan, Zamudio, Jorge, Gurevich, Tanya, Chodick, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345081/ https://www.ncbi.nlm.nih.gov/pubmed/37069439 http://dx.doi.org/10.1007/s00415-023-11714-1 |
Ejemplares similares
-
Epidemiology of Progressive Supranuclear Palsy: Real World Data from the Second Largest Health Plan in Israel
por: Barer, Yael, et al.
Publicado: (2022) -
Healthcare utilization, costs, and epidemiology of Huntington’s disease in Israel
por: Barer, Yael, et al.
Publicado: (2023) -
The Clinical and Economic Burden of Tardive Dyskinesia in Israel: Real-World Data Analysis
por: Barer, Yael, et al.
Publicado: (2022) -
Risk of Parkinson Disease Among Adults With vs Without Posttraumatic Stress Disorder
por: Barer, Yael, et al.
Publicado: (2022) -
Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease
por: Thaler, Avner, et al.
Publicado: (2022)